Suppr超能文献

高剂量用药:高效力药用大麻诱发精神病的案例研究

High Prescribing: A Case Study of High-Potency Medicinal Cannabis Inducing Psychosis.

作者信息

Bradlow Richard C J, Wright Sophie, Szrajbman Vaz Da Silva Anamaria, Armstrong Ferghal

机构信息

Psychiatry, Lismore Base Hospital, Lismore, Australia.

Department of Psychiatry, Monash University, Clayton, Australia.

出版信息

Case Rep Psychiatry. 2024 Dec 7;2024:8870476. doi: 10.1155/crps/8870476. eCollection 2024.

Abstract

There has been a recent significant increase in medical cannabis prescribing in Australia despite weak evidence for its effectiveness in treating the most common indications. Concern has been raised about the potential harms of inappropriate prescription of cannabis; however, there have been no prior published cases of psychosis secondary to medicinal cannabis in Australia. We present a case of a 21-year-old Indigenous male with psychosis following switching from illicitly obtained cannabis to prescription cannabis, which resulted in Othello delusions towards his partner, violence towards her and ultimately an attempt to end his life. Cannabis use is linked to the development of a psychotic illness whether it is prescribed or obtained illicitly. People who are prescribed cannabis are also at an elevated risk of developing cannabis use disorder (CUD). Cannabis prescribers need to screen for risk factors of drug-induced psychosis such as a family member with a psychotic illness, review patients regularly and provide harm minimisation advice to prevent damage from their prescription. There are clear dangers to overprescribing medicinal cannabis and the care that needs to be taken by prescribers to avoid them. There is a need for a change in the regulation of cannabis prescribing in Australia. Further research is warranted on the effects of the increase in prevalence of cannabis prescribing.

摘要

尽管医用大麻在治疗最常见病症方面的有效性证据不足,但澳大利亚近期医用大麻的处方量仍显著增加。人们对大麻不适当处方的潜在危害表示担忧;然而,此前澳大利亚尚无因医用大麻导致精神错乱的公开病例。我们报告一例21岁的原住民男性病例,该患者从非法获取大麻转而使用处方大麻后出现精神错乱,导致对其伴侣产生嫉妒妄想、对她实施暴力,最终企图自杀。无论大麻是通过处方获取还是非法获取,使用大麻都与精神疾病的发展有关。开具大麻处方的人患大麻使用障碍(CUD)的风险也会升高。大麻开方者需要筛查药物性精神病的风险因素,如家族中有精神疾病患者,定期复查患者,并提供危害最小化建议,以防止其处方造成损害。过度开具医用大麻存在明显危险,开方者需谨慎避免。澳大利亚有必要改变大麻处方的监管规定。有必要对大麻处方量增加的影响进行进一步研究。

相似文献

本文引用的文献

4
Use of Cannabidiol in the Management of Insomnia: A Systematic Review.大麻二酚在失眠管理中的应用:一项系统综述。
Cannabis Cannabinoid Res. 2023 Apr;8(2):213-229. doi: 10.1089/can.2022.0122. Epub 2022 Sep 23.
7
Cannabis use and psychosis: a review of reviews.大麻使用与精神病:综述研究。
Eur Arch Psychiatry Clin Neurosci. 2020 Jun;270(4):403-412. doi: 10.1007/s00406-019-01068-z. Epub 2019 Sep 28.

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验